Bullish insider activity, combined with institutional buying, and raising of Q2 guidance. I like it. Actually, I wonder whether a company like this could be acquired by some like LIFE or AFFX. I noticed Gen-probe was recently picked up by Hologic. Thoughts?
I also notice an impending Golden Cross forming in the charts. Upside places my target at $8.30 for GNMK.